{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:04:10Z","timestamp":1792883050172,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":2139,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 GM076343"],"award-info":[{"award-number":["R01 GM076343"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RR01778"],"award-info":[{"award-number":["RR01778"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["GM103420"],"award-info":[{"award-number":["GM103420"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RR00129"],"award-info":[{"award-number":["RR00129"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["GM103393"],"award-info":[{"award-number":["GM103393"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1074\/jbc.m114.610998","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T02:20:36Z","timestamp":1412907636000},"page":"32952-32964","source":"Crossref","is-referenced-by-count":119,"title":["Structures of Human Steroidogenic Cytochrome P450 17A1 with Substrates"],"prefix":"10.1016","volume":"289","author":[{"given":"Elyse M.","family":"Petrunak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha M.","family":"DeVore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Porubsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M114.610998_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev"},{"key":"10.1074\/jbc.M114.610998_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbapap.2010.06.021","article-title":"At the crossroads of steroid hormone biosynthesis: the role, substrate specificity and evolutionary development of CYP17","volume":"1814","author":"Gilep","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M114.610998_bib3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.28509","article-title":"Annual report to the nation on the status of cancer, 1975\u20132010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer","volume":"120","author":"Edwards","year":"2014","journal-title":"Cancer"},{"key":"10.1074\/jbc.M114.610998_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/PPO.0b013e31827e0b6f","article-title":"Agents that target androgen synthesis in castration-resistant prostate cancer","volume":"19","author":"Ferraldeschi","year":"2013","journal-title":"Cancer J"},{"key":"10.1074\/jbc.M114.610998_bib5","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono","year":"2011","journal-title":"New Engl. J. Med"},{"key":"10.1074\/jbc.M114.610998_bib6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2310\/JIM.0b013e3182408567","article-title":"Human steroid biosynthesis for the oncologist","volume":"60","author":"Auchus","year":"2012","journal-title":"J. Investig. Med"},{"key":"10.1074\/jbc.M114.610998_bib7","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/annonc\/mdt136","article-title":"Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)","volume":"24","author":"Loriot","year":"2013","journal-title":"Ann. Oncol"},{"key":"10.1074\/jbc.M114.610998_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature10743","article-title":"Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001","volume":"482","author":"DeVore","year":"2012","journal-title":"Nature"},{"key":"10.1074\/jbc.M114.610998_bib9","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ctrv.2013.03.003","article-title":"Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone","volume":"39","author":"Pia","year":"2013","journal-title":"Cancer Treat. Rev"},{"key":"10.1074\/jbc.M114.610998_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/jc.2011-2189","article-title":"Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer","volume":"97","author":"Attard","year":"2012","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1074\/jbc.M114.610998_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0303-7207(91)90145-I","article-title":"Markedly increased expression of cytochrome P-450 17\u03b1-hydroxylase (P-450c17) mRNA in adrenocortical adenomas from patients with Cushing's syndrome","volume":"80","author":"Ogo","year":"1991","journal-title":"Mol. Cell Endocrinol"},{"key":"10.1074\/jbc.M114.610998_bib12","first-page":"701","article-title":"Congenital adrenal hyperplasia: biochemical and molecular perspectives","volume":"41","author":"Maitra","year":"2003","journal-title":"Indian J. Exp. Biol"},{"key":"10.1074\/jbc.M114.610998_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0303-7207(98)00177-4","article-title":"Role of cytochrome P450c17 in polycystic ovary syndrome","volume":"145","author":"Qin","year":"1998","journal-title":"Mol. Cell Endocrinol"},{"key":"10.1074\/jbc.M114.610998_bib14","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1210\/en.2002-220456","article-title":"Molecular evolution of adrenarche: Structural and functional analysis of p450c17 from four primate species","volume":"143","author":"Arlt","year":"2002","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.M114.610998_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1196\/annals.1290.005","article-title":"Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome","volume":"997","author":"Strauss","year":"2003","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1074\/jbc.M114.610998_bib16","first-page":"98","article-title":"Progesterone 16\u03b1-hydroxylase activity is catalyzed by human cytochrome P450 17\u03b1-hydroxylase","volume":"77","author":"Swart","year":"1993","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1074\/jbc.M114.610998_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jsbmb.2009.12.014","article-title":"A single amino acid residue, Ala 105, confers 16\u03b1-hydroxylase activity to human cytochrome P450 17\u03b1-hydroxylase\/17,20-lyase","volume":"119","author":"Swart","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"10.1074\/jbc.M114.610998_bib18","doi-asserted-by":"crossref","first-page":"17734","DOI":"10.1074\/jbc.M110.123711","article-title":"Kinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1","volume":"285","author":"Sohl","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.610998_bib19","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1210\/jc.2003-030143","article-title":"The 17,20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway","volume":"88","author":"Fl\u00fcck","year":"2003","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1074\/jbc.M114.610998_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jbt.20174","article-title":"Mechanisms of cytochrome P450 substrate oxidation: MiniReview","volume":"21","author":"Guengerich","year":"2007","journal-title":"J. Biochem. Mol. Toxicol"},{"key":"10.1074\/jbc.M114.610998_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-291X(78)91643-1","article-title":"Aliphatic hydroxylation by highly purified liver microsomal cytochrome P-450. Evidence for a carbon radical intermediate","volume":"81","author":"Groves","year":"1978","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M114.610998_bib22","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1021\/bi00180a039","article-title":"Mechanism of the acyl-carbon cleavage and related reactions catalyzed by multifunctional P-450s: Studies on cytochrome P-450(17)\u03b1","volume":"33","author":"Akhtar","year":"1994","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M114.610998_bib23","doi-asserted-by":"crossref","first-page":"16245","DOI":"10.1021\/ja4086403","article-title":"Kinetic solvent isotope effect in human P450 CYP17A1-mediated androgen formation: evidence for a reactive peroxoanion intermediate","volume":"135","author":"Gregory","year":"2013","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.M114.610998_bib24","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1002\/anie.201300760","article-title":"Differential hydrogen bonding in human CYP17 dictates hydroxylation versus lyase chemistry","volume":"52","author":"Gregory","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl"},{"key":"10.1074\/jbc.M114.610998_bib25","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.610998_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/abbi.1995.1173","article-title":"The role of cytochrome b5 in the biosynthesis of androgens by human P450c17","volume":"317","author":"Katagiri","year":"1995","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1074\/jbc.M114.610998_bib27","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/bj3080901","article-title":"Modulation of the activity of human 17\u03b1-hydroxylase-17,20-lyase (CYP17) by cytochrome b5: endocrinological and mechanistic implications","volume":"308","author":"Lee-Robichaud","year":"1995","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M114.610998_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0006-291X(82)90850-6","article-title":"Cytochrome b5 stimulates purified testicular microsomal cytochrome P-450 (C21 side-chain cleavage)","volume":"108","author":"Onoda","year":"1982","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M114.610998_bib29","doi-asserted-by":"crossref","first-page":"E465","DOI":"10.1210\/jc.2011-2413","article-title":"A missense mutation in the human cytochrome b5 gene causes 46, XY disorder of sex development due to true isolated 17,20-lyase deficiency","volume":"97","author":"Idkowiak","year":"2012","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1074\/jbc.M114.610998_bib30","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1210\/jc.2008-1745","article-title":"Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X","volume":"95","author":"Kok","year":"2010","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1074\/jbc.M114.610998_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/bi051623y","article-title":"Human cytochrome b5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17","volume":"45","author":"Naffin-Olivos","year":"2006","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M114.610998_bib32","first-page":"1169","article-title":"Molecular modeling of human P450c17 (17\u03b1-hydroxylase\/17,20-lyase): insights into reaction mechanisms and effects of mutations","volume":"13","author":"Auchus","year":"1999","journal-title":"Mol. Endocrinol"},{"key":"10.1074\/jbc.M114.610998_bib33","first-page":"435","article-title":"Molecular modelling of 17\u03b1-hydroxylase-17,20-lyase","volume":"56","author":"Schappach","year":"2001","journal-title":"Pharmazie"},{"key":"10.1074\/jbc.M114.610998_bib34","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jmb.2010.05.069","article-title":"Molecular modeling on inhibitor complexes and active-site dynamics of cytochrome P450 C17, a target for prostate cancer therapy","volume":"400","author":"Haider","year":"2010","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.M114.610998_bib35","first-page":"392","article-title":"Modeling and mutagenesis of the active site of human P450c17","volume":"8","author":"Lin","year":"1994","journal-title":"Mol. Endocrinol"},{"key":"10.1074\/jbc.M114.610998_bib36","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/0006-291X(90)90806-X","article-title":"A molecular model for the enzyme cytochrome P450(17\u03b1), a major target for the chemotherapy of prostatic cancer","volume":"171","author":"Laughton","year":"1990","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M114.610998_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M114.610998_bib38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr"},{"key":"10.1074\/jbc.M114.610998_bib39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M114.610998_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M114.610998_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1107\/S0907444993011333","article-title":"Detection, delineation, measurement and display of cavities in macromolecular structures","volume":"50","author":"Kleywegt","year":"1994","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M114.610998_bib42","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2012"},{"key":"10.1074\/jbc.M114.610998_bib43","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/en.2011-0230","article-title":"High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase","volume":"152","author":"Sandee","year":"2011","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.M114.610998_bib44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/FTD.0b013e318286ee02","article-title":"GC-MS-based quantitative signatures of cytochrome P450-mediated steroid oxidation induced by rifampicin","volume":"35","author":"Moon","year":"2013","journal-title":"Ther. Drug Monit"},{"key":"10.1074\/jbc.M114.610998_bib45","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1124\/dmd.109.026765","article-title":"Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes","volume":"37","author":"DeVore","year":"2009","journal-title":"Drug Metab. Dispos"},{"key":"10.1074\/jbc.M114.610998_bib46","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1021\/bi300895w","article-title":"Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates","volume":"51","author":"Yoshimoto","year":"2012","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M114.610998_bib47","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/S0021-9258(19)69538-4","article-title":"Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of A C21 steroid side-chain cleavage system (17\u03b1-hydroxylase-C17,20-lyase)","volume":"256","author":"Nakajin","year":"1981","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.610998_bib48","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1126\/science.287.5458.1615","article-title":"The catalytic pathway of cytochrome p450cam at atomic resolution","volume":"287","author":"Schlichting","year":"2000","journal-title":"Science"},{"key":"10.1074\/jbc.M114.610998_bib49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1021\/bi4014424","article-title":"Resonance Raman spectroscopy reveals that substrate structure selectively impacts the heme-bound diatomic ligands of CYP17","volume":"53","author":"Mak","year":"2014","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M114.610998_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1677\/joe.1.06375","article-title":"Cytochrome b5 modulation of 17\u03b1 hydroxylase and 17\u201320 lyase (CYP17) activities in steroidogenesis","volume":"187","author":"Akhtar","year":"2005","journal-title":"J. Endocrinol"},{"key":"10.1074\/jbc.M114.610998_bib51","doi-asserted-by":"crossref","first-page":"17008","DOI":"10.1074\/jbc.M113.468926","article-title":"Substrate-modulated cytochrome P450 17A1 and cytochrome b5 interactions revealed by NMR","volume":"288","author":"Estrada","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.610998_bib52","doi-asserted-by":"crossref","first-page":"14310","DOI":"10.1074\/jbc.M114.560144","article-title":"Human cytochrome P450 17A1 conformational selection: modulation by ligand and cytochrome b5","volume":"289","author":"Estrada","year":"2014","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.610998_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2013.11.094","article-title":"Active site proton delivery and the lyase activity of human CYP17A1","volume":"443","author":"Khatri","year":"2014","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M114.610998_bib54","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: Implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.610998_bib55","doi-asserted-by":"crossref","first-page":"23903","DOI":"10.1074\/jbc.M113.460048","article-title":"Phosphorylation of human cytochrome P450c17 by p38\u03b1 selectively increases 17,20-lyase activity and androgen biosynthesis","volume":"288","author":"Tee","year":"2013","journal-title":"J. Biol. Chem"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820474927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820474927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M114.610998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T16:24:44Z","timestamp":1641313484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820474927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":55,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0021925820474927"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m114.610998","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}